The Caris Precision Oncology Alliance (POA) Executive Committee is responsible for establishing appropriate molecular testing principles to serve as guidelines for the consistent application of tumor profiling across the oncology community. The executive committee is also charged with facilitating collaborative research studies across the POA and coordinating outcome tracking initiatives to generate and document additional medical evidence for the appropriate use and impact of profiling.

Chairman, Precision Oncology Alliance

Chief, Division Hematology and Oncology, Department of Medicine, Georgetown University

Professor of Medicine and Oncology, Georgetown University

Executive Director, West Cancer Center

Division Chief, Hematology Oncology, The University of Tennessee Health Science Center

Associate Center Director for Translational Sciences, Karmanos Cancer Institute

Associate Director for Clinical Research, USC Norris Comprehensive Cancer Center

Wafik El-Deiry, MD, PhD - Caris COE

Associate Dean for Oncologic Sciences, Brown University

Founder, Oncoceutics

Deputy Director, University of Cincinnati Cancer Institute and The Barrett Cancer Center

Paul & Carolyn Flory Endowed Professor, Obstetrics & Gynecology, University of Cincinnati